LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study

ADHD pharmacogenetics across the life cycle: New findings and perspectives

(2014) Estela Maria Bruxel et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

LPHN3, a presynaptic adhesion-GPCR implicated in ADHD, regulates the strength of neocortical layer 2/3 synaptic input to layer 5

(2014) Matthew L O’Sullivan et al.   Neural Development

Genetics of attention-deficit/hyperactivity disorder: current findings and future directions

(2013) Glaucia Chiyoko Akutagava-Martins et al.   Expert Review of Neurotherapeutics

The evolution, impact and properties of exonic splice enhancers

(2013) Eva Cáceres et al.   GENOME BIOLOGY

Refining psychiatric phenotypes for response to treatment: Contribution of LPHN3 in ADHD

(2012) Aurelie Labbe et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Influence of a Latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD)

(2012) Andreas J. Fallgatter et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy

(2012) Zia Choudhry et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review

(2012) Erik G. Willcutt   Neurotherapeutics

Catechol-O-Methyltransferase Valine158Methionine Polymorphism Moderates Methylphenidate Effects on Oppositional Symptoms in Boys with Attention-Deficit/Hyperactivity Disorder

(2011) Angélica Salatino-Oliveira et al.   BIOLOGICAL PSYCHIATRY

Pharmacogenetic Predictors of Methylphenidate Dose-Response in Attention-Deficit/Hyperactivity Disorder

(2011) Tanya E. Froehlich et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD

(2011) M Jain et al.   MOLECULAR PSYCHIATRY

A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome

(2011) M T Acosta et al.   Translational Psychiatry

Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility

(2010) Sabina Domené et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Clinically Relevant Doses of Methylphenidate Significantly Occupy Norepinephrine Transporters in Humans In Vivo

(2010) Jonas Hannestad et al.   BIOLOGICAL PSYCHIATRY

Pharmacogenetic Approach for a Better Drug Treatment in Children

(2010) Guilherme Polanczyk et al.   CURRENT PHARMACEUTICAL DESIGN

Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study

(2010) M. Ribasés et al.   GENES BRAIN AND BEHAVIOR

A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication

(2010) M Arcos-Burgos et al.   MOLECULAR PSYCHIATRY

A current update on ADHD pharmacogenomics

(2010) Christian Kieling et al.   PHARMACOGENOMICS

Candidate gene studies of ADHD: a meta-analytic review

(2009) Ian R. Gizer et al.   HUMAN GENETICS

Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel

(2009) Ney P.C. Santos et al.   HUMAN MUTATION

A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder

(2009) James J. McGough et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Developmental regulation of neural cell adhesion molecule in human prefrontal cortex

(2009) E.T. Cox et al.   NEUROSCIENCE

SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies

(2009) Zongli Xu et al.   NUCLEIC ACIDS RESEARCH

Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype Data

(2008) Frank Dudbridge   HUMAN HEREDITY